The IP COP sees in the future the supply of clinical materials becoming a two-way street, with information flowing upstream from the patients and sites to drive the downstream flow of user focused products and services. This first patient survey is a small but important step. The Patient Survey Project Team is undertaking a survey of clinical trial patients globally to gain their feedback on the suitability of clinical materials that are currently provided and to obtain the patients’ suggestions for improvements. The goals of the Project are: 1. Understanding of patient experience with Investigational Products. 2. Understanding of the impact of key patient differentiators. 3. Providing a data set that impacts decisions, opens new areas of inquiry, and generates practice Implications for both good manufacturing practices (cGMPs) and the GCP-GMP interface. 4. Increasing collaboration between global regulatory bodies, companies engaged in the IMP sector, and facilitator organizations like ISPE so that enlightened global Guidance(s) result. The Read out will include: • key findings on Patient experience related to IMPs i. Patients current and recent experience ii. Patients Attitudes and Perceptions iii. Improvements for the future.